ALVOTECH ($ALVO) posted quarterly earnings results on Wednesday, August 13th. The company reported earnings of $0.14 per share, beating estimates of -$0.03 by $0.17. The company also reported revenue of $173,340,000, beating estimates of $122,920,200 by $50,419,800.
You can see Quiver Quantitative's $ALVO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALVOTECH Hedge Fund Activity
We have seen 25 institutional investors add shares of ALVOTECH stock to their portfolio, and 20 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,401,421 shares (+inf%) to their portfolio in Q1 2025, for an estimated $13,551,741
- SCULPTOR CAPITAL LP removed 565,359 shares (-93.3%) from their portfolio in Q1 2025, for an estimated $5,467,021
- MORGAN STANLEY removed 469,680 shares (-31.7%) from their portfolio in Q1 2025, for an estimated $4,541,805
- NORGES BANK added 180,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,641,599
- ROYCE & ASSOCIATES LP added 102,031 shares (+59.7%) to their portfolio in Q2 2025, for an estimated $930,522
- LEGAL & GENERAL GROUP PLC added 95,331 shares (+17.0%) to their portfolio in Q2 2025, for an estimated $869,418
- POINTSTATE CAPITAL LP removed 67,040 shares (-5.4%) from their portfolio in Q1 2025, for an estimated $648,276
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ALVOTECH Analyst Ratings
Wall Street analysts have issued reports on $ALVO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 07/18/2025
To track analyst ratings and price targets for ALVOTECH, check out Quiver Quantitative's $ALVO forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
